Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma

被引:0
|
作者
Xu Yang
Baofeng Lian
Nan Zhang
Junyu Long
Yiran Li
Jingnan Xue
Xiangqi Chen
Yunchao Wang
Yanyu Wang
Ziyu Xun
Mingjian Piao
Chenpei Zhu
Shanshan Wang
Huishan Sun
Zhijian Song
Leilei Lu
Xiaowei Dong
Aodi Wang
Wenjin Liu
Jie Pan
Xiaorong Hou
Mei Guan
Li Huo
Jie Shi
Haohai Zhang
Jinxue Zhou
Zhenhui Lu
Yilei Mao
Xinting Sang
Liqun Wu
Xiaobo Yang
Kai Wang
Haitao Zhao
机构
[1] Peking Union Medical College Hospital,Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Breast Surgery
[3] OrigiMed Co.,Department of Radiology
[4] Ltd,Department of Radiotherapy
[5] Peking,Department of Medical Oncology
[6] Union Medical College Hospital,Department of Nuclear Medicine
[7] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Pathology
[8] Peking Union Medical College Hospital,Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine
[9] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Hepatobiliary and Pancreatic Surgery
[10] Peking Union Medical College Hospital,Hepatobiliary and Pancreatic Surgery
[11] Chinese Academy of Medical Sciences & Peking Union Medical College,Liver Disease Center
[12] Peking Union Medical College Hospital,undefined
[13] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[14] Peking Union Medical College Hospital,undefined
[15] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[16] Peking Union Medical College Hospital,undefined
[17] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[18] Beth Israel Deaconess Medical Center,undefined
[19] Harvard Medical School,undefined
[20] The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital,undefined
[21] Shenzhen Qianhai Shekou Free Trade Zone Hospital,undefined
[22] Affiliated Hospital of Qingdao University,undefined
来源
BMC Medicine | / 22卷
关键词
Microsatellite instability-high; Cholangiocarcinoma; PD-1 inhibitor; PD-L1 expression; Tumor mutation burden; Overall survival; Immune checkpoint inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
    Yang, Xu
    Lian, Baofeng
    Zhang, Nan
    Long, Junyu
    Li, Yiran
    Xue, Jingnan
    Chen, Xiangqi
    Wang, Yunchao
    Wang, Yanyu
    Xun, Ziyu
    Piao, Mingjian
    Zhu, Chenpei
    Wang, Shanshan
    Sun, Huishan
    Song, Zhijian
    Lu, Leilei
    Dong, Xiaowei
    Wang, Aodi
    Liu, Wenjin
    Pan, Jie
    Hou, Xiaorong
    Guan, Mei
    Huo, Li
    Shi, Jie
    Zhang, Haohai
    Zhou, Jinxue
    Lu, Zhenhui
    Mao, Yilei
    Sang, Xinting
    Wu, Liqun
    Yang, Xiaobo
    Wang, Kai
    Zhao, Haitao
    BMC MEDICINE, 2024, 22 (01)
  • [2] Genomic characterization and translational immunotherapy of microsatellite instability-high (MSI-H) in cholangiocarcinoma.
    Yang, Xu
    Lian, Baofeng
    Li, Yiran
    Xue, Jinnan
    Wang, Yunchao
    Wang, Yanyu
    Xun, Ziyu
    Zhang, Nan
    Sun, Huishan
    Long, Junyu
    Song, Zhijian
    Lu, Leilei
    Pan, Jie
    Zhao, Lin
    Guan, Mei
    Yang, Xiaobo
    Mao, Yilei
    Sang, Xinting
    Wang, Kai
    Zhao, Hai-Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
    Kim, Jung Ho
    Seo, Mi-Kyoung
    Lee, Ji Ae
    Yoo, Seung-Yeon
    Oh, Hyeon Jeong
    Kang, Hyundeok
    Cho, Nam-Yun
    Bae, Jeong Mo
    Kang, Gyeong Hoon
    Kim, Sangwoo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
  • [4] Successful pembrolizumab treatment of microsatellite instability-high intrahepatic cholangiocarcinoma: A case report
    Ikeda, Yuki
    Ono, Michihiro
    Ohmori, Ginji
    Ameda, Saki
    Yamada, Michiko
    Abe, Tomoyuki
    Fujii, Shigeyuki
    Fujita, Miri
    Maeda, Masahiro
    CLINICAL CASE REPORTS, 2021, 9 (04): : 2259 - 2263
  • [5] Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
    Katsuya Toshida
    Shinji Itoh
    Tomoharu Yoshizumi
    Tomonari Shimagaki
    Huanlin Wang
    Takeshi Kurihara
    Takeo Toshima
    Yoshihiro Nagao
    Noboru Harada
    Eiji Oki
    Yoshiaki Nakamura
    Takayuki Yoshino
    Masaki Mori
    Clinical Journal of Gastroenterology, 2021, 14 : 1459 - 1463
  • [6] Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
    Toshida, Katsuya
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Shimagaki, Tomonari
    Wang, Huanlin
    Kurihara, Takeshi
    Toshima, Takeo
    Nagao, Yoshihiro
    Harada, Noboru
    Oki, Eiji
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    Mori, Masaki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1459 - 1463
  • [7] Comprehensive Genomic Profiling of Microsatellite Instability-High Lung Cancer in China
    Zhou, C.
    Li, Q.
    He, Z.
    Chen, R.
    Yu, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1167 - S1167
  • [8] Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacy
    Landre, Thierry
    Des Guetz, Gaetan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [9] Fusion kinases identified by genomic analyses of microsatellite instability-high colorectal cancers
    Sato, Kazuhito
    Kawazu, Masahito
    Yamamoto, Yoko
    Ueno, Toshihide
    Kojima, Shinya
    Soda, Manabu
    Nagae, Genta
    Kohsaka, Shinji
    Yamashita, Yoshihiro
    Iinuma, Hisae
    Aburatani, Hiroyuki
    Watanabe, Toshiaki
    Mano, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 639 - 639
  • [10] Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor
    Cheng, Zhuo
    Zeng, Tianmei
    Yang, Guang
    Liu, Di
    Zheng, Zhi
    Yuan, Zhengang
    LIVER CANCER, 2023, 12 (03) : 281 - 288